Granite Point Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-128,822
Closed -$4.44M 111
2022
Q1
$4.44M Sell
128,822
-68,391
-35% -$2.22M 0.93% 21
2021
Q4
$9.82M Hold
197,213
1.66% 9
2021
Q3
$9.07M Sell
197,213
-12,787
-6% -$507K 0.69% 15
2021
Q2
$6.28M Sell
210,000
-94,076
-31% -$1.92M 0.23% 26
2021
Q1
$6.18M Buy
+304,076
New +$6.41M 0.23% 34

Other funds holding ASPN

Granite Point Capital Management's ASPN Position: Q2 2022 in Review

Granite Point Capital Management sold out of Aspen Aerogels (ASPN) in Q2 2022, closing a stake of 128,822 shares — an estimated $4.44M sold.

Granite Point Capital Management first reported a position in ASPN in Q1 2021 and held it in 5 quarters. The position peaked at $9.82M in Q4 2021. 146 funds tracked by Wall St. Rank hold ASPN as of Q2 2022.

  • Granite Point Capital Management reported no remaining Aspen Aerogels position as of Q2 2022 after selling out during the quarter.
  • Granite Point Capital Management sold 128,822 Aspen Aerogels shares in Q2 2022, an estimated $4.44M.
  • Granite Point Capital Management first reported a position in Aspen Aerogels in Q1 2021 and held it in 5 quarters.
  • Granite Point Capital Management's Aspen Aerogels position peaked at $9.82M in Q4 2021.
  • 146 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2022.

Based on Granite Point Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.